Newsroom
Walgreens Sells $1.1 Billion Stake in Distributor Cencora, Faces Multiple Class Action Lawsuits
By KlickAnalytics Data Insights | August 1, 2024 08:03PM ET
Key Points
- Walgreens Boots Alliance sells more shares of Cencora for $1.1 billion, using proceeds for debt paydown and general corporate purposes
- Multiple law firms alert shareholders of lead plaintiff deadlines in securities violation lawsuits against Walgreens Boots Alliance
- Investors urged to join class action lawsuits against Walgreens Boots Alliance to potentially recover losses
- Zacks.com highlights investor interest in Walgreens and its potential prospects amid legal challenges
- Shareholders with substantial losses in Walgreens have the opportunity to lead class action lawsuits
Walgreens Boots Alliance has divested additional shares of drug distributor Cencora, generating approximately $1.1 billion in proceeds. The funds from the stake sale will be primarily allocated towards debt repayment and general corporate uses. The move comes as Walgreens continues to strategically realign its investments and financial resources.
Several law firms, including Levi & Korsinsky, The Rosen Law Firm, Pomerantz Law Firm, Bronstein, Gewirtz & Grossman LLC, and Robbins Geller Rudman & Dowd LLP, have issued alerts to shareholders regarding pending class action lawsuits against Walgreens Boots Alliance. These legal challenges pertain to alleged securities law violations during a specific period ranging from October 12, 2023, to June 26, 2024.
Investors who experienced financial losses on their Walgreens Boots Alliance investments within the mentioned timeframe are being encouraged to explore the option of joining these class action lawsuits. The lawsuits aim to offer a potential avenue for affected shareholders to seek compensation without incurring out-of-pocket expenses through contingency fee arrangements.
Amidst the legal proceedings, Zacks.com has observed heightened interest from investors in Walgreens Boots Alliance. With factors influencing the stock's future prospects being closely scrutinized, it is essential for shareholders to stay informed and engaged with developments surrounding the company.
For shareholders who have incurred significant losses with Walgreens Boots Alliance, there is the opportunity to actively participate in the class action lawsuits and potentially play a lead role in seeking recourse for any damages suffered. The upcoming deadline for appointing a lead plaintiff in the litigation presents an important window for affected investors to assert their rights and seek redress for their losses.
For more information:
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with